Quantifying Cell Death Induced by the NLRC4 Inflammasome.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2023
Historique:
medline: 15 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: ppublish

Résumé

The Nod-like Receptor (NLR) apoptosis inhibitory proteins (NAIPs) are cytosolic receptors that sense cytosolic bacterial proteins. NAIP ligation induces its association with NLRC4, leading to the assembly of the NAIP/NLRC4 inflammasome, which induces the activation of the caspase-1 protease. Caspase-1 then cleaves pro-interleukin (IL)-1β, pro-IL-18, and gasdermin D and induces a form of pro-inflammatory cell death, pyroptosis. These processes culminate in host defense against bacterial infection. Here we describe methods for activating NAIP/NLRC4 inflammasome signalling in human and murine macrophages and quantifying inflammasome-induced cell death.

Identifiants

pubmed: 37578724
doi: 10.1007/978-1-0716-3350-2_13
doi:

Substances chimiques

Inflammasomes 0
Calcium-Binding Proteins 0
Apoptosis Regulatory Proteins 0
Caspases EC 3.4.22.-
Caspase 1 EC 3.4.22.36
NLRC4 protein, human 0
CARD Signaling Adaptor Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-210

Informations de copyright

© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426
doi: 10.1016/S1097-2765(02)00599-3 pubmed: 12191486
Boucher D, Monteleone M, Coll RC et al (2018) Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J Exp Med 215:827–840. https://doi.org/10.1084/jem.20172222
doi: 10.1084/jem.20172222 pubmed: 29432122 pmcid: 5839769
Chan AH, Schroder K (2020) Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med 217:e20190314. https://doi.org/10.1084/jem.20190314
doi: 10.1084/jem.20190314 pubmed: 31611248
Rauch I, Tenthorey JL, Nichols RD et al (2016) NAIP proteins are required for cytosolic detection of specific bacterial ligands in vivo. J Exp Med 213:657–665. https://doi.org/10.1084/jem.20151809
doi: 10.1084/jem.20151809 pubmed: 27045008 pmcid: 4854734
Zhao Y, Yang J, Shi J et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596–600. https://doi.org/10.1038/nature10510
doi: 10.1038/nature10510 pubmed: 21918512
Kofoed EM, Vance RE (2011) Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477:592–595. https://doi.org/10.1038/nature10394
doi: 10.1038/nature10394 pubmed: 21874021 pmcid: 3184209
Yang J, Zhao Y, Shi J, Shao F (2013) Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc Natl Acad Sci 110:14408–14413. https://doi.org/10.1073/pnas.1306376110
doi: 10.1073/pnas.1306376110 pubmed: 23940371 pmcid: 3761597
von Moltke J, Trinidad NJ, Moayeri M et al (2012) Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490:107–111. https://doi.org/10.1038/nature11351
doi: 10.1038/nature11351
Kuida K, Lippke JA, Ku G et al (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000–2003. https://doi.org/10.1126/science.7535475
doi: 10.1126/science.7535475 pubmed: 7535475
Chen KW, Monteleone M, Boucher D et al (2018) Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps. Sci Immunol 3. https://doi.org/10.1126/sciimmunol.aar6676
Linton SD (2005) Caspase inhibitors: a pharmaceutical industry perspective. Curr Top Med Chem 5:1697–1717. https://doi.org/10.2174/156802605775009720
doi: 10.2174/156802605775009720 pubmed: 16375749

Auteurs

Stefan Emming (S)

Institute for Molecular Bioscience, and Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia.

Mercedes M Monteleone (MM)

Institute for Molecular Bioscience, and Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia.

Hiroto Kambara (H)

Quench Bio, Inc., Cambridge, MA, USA.

Alina Starchenko (A)

Quench Bio, Inc., Cambridge, MA, USA.

Jennifer Alley (J)

Quench Bio, Inc., Cambridge, MA, USA.

Michael A Nolan (MA)

Quench Bio, Inc., Cambridge, MA, USA.

Wei Li (W)

Quench Bio, Inc., Cambridge, MA, USA.

Iain Kilty (I)

Quench Bio, Inc., Cambridge, MA, USA.

Kate Schroder (K)

Institute for Molecular Bioscience, and Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia. k.schroder@imb.uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH